The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hematologic Malignancies Detection Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Hematologic Malignancies Detection Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1753832

No of Pages : 101

Ask Your Query

Synopsis
The global Hematologic Malignancies Detection market size was valued at USD 2299.4 million in 2022 and is forecast to a readjusted size of USD 5743.9 million by 2029 with a CAGR of 14.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Increasing prevalence of hematological malignancies, emerging new technologies and methods for testing, patient preference for testing treatments, and increasing regulation across the healthcare industry are the key factors driving the growth of hematological malignancies testing market revenue.

Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.

This report is a detailed and comprehensive analysis for global Hematologic Malignancies Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Hematologic Malignancies Detection market size and forecasts, in consumption value ($ Million), 2018-2029
Global Hematologic Malignancies Detection market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Hematologic Malignancies Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Hematologic Malignancies Detection market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hematologic Malignancies Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Hematologic Malignancies Detection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ArcherDx, Bio-Rad Laboratories, sysmex, Invitae and NeoGenomics Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Hematologic Malignancies Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Polymerase Chain Reaction
  • Immunochemistry
  • Next Generation Sequencing
  • Fluorescence in Situ Hybridization
  • Others

Market segment by Application

  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Leukemia
  • Myeloproliferative Neoplasms
  • Lymphoma
  • Others

Market segment by players, this report covers

  • ArcherDx
  • Bio-Rad Laboratories
  • sysmex
  • Invitae
  • NeoGenomics Laboratories
  • Abbott Laboratories
  • Cancer Genetics
  • Adaptive Biotechnologies Corporation
  • Asuragen
  • Invivoscribe
  • Nanjing Shihejiyin Technology
  • Annaroad Gene Technology
  • BGI Genomics

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Hematologic Malignancies Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hematologic Malignancies Detection, with revenue, gross margin and global market share of Hematologic Malignancies Detection from 2018 to 2023.
Chapter 3, the Hematologic Malignancies Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hematologic Malignancies Detection market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Hematologic Malignancies Detection.
Chapter 13, to describe Hematologic Malignancies Detection research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Hematologic Malignancies Detection
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hematologic Malignancies Detection by Type
1.3.1 Overview: Global Hematologic Malignancies Detection Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Hematologic Malignancies Detection Consumption Value Market Share by Type in 2022
1.3.3 Polymerase Chain Reaction
1.3.4 Immunochemistry
1.3.5 Next Generation Sequencing
1.3.6 Fluorescence in Situ Hybridization
1.3.7 Others
1.4 Global Hematologic Malignancies Detection Market by Application
1.4.1 Overview: Global Hematologic Malignancies Detection Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Multiple Myeloma
1.4.3 Myelodysplastic Syndrome
1.4.4 Leukemia
1.4.5 Myeloproliferative Neoplasms
1.4.6 Lymphoma
1.4.7 Others
1.5 Global Hematologic Malignancies Detection Market Size & Forecast
1.6 Global Hematologic Malignancies Detection Market Size and Forecast by Region
1.6.1 Global Hematologic Malignancies Detection Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Hematologic Malignancies Detection Market Size by Region, (2018-2029)
1.6.3 North America Hematologic Malignancies Detection Market Size and Prospect (2018-2029)
1.6.4 Europe Hematologic Malignancies Detection Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Hematologic Malignancies Detection Market Size and Prospect (2018-2029)
1.6.6 South America Hematologic Malignancies Detection Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Hematologic Malignancies Detection Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 ArcherDx
2.1.1 ArcherDx Details
2.1.2 ArcherDx Major Business
2.1.3 ArcherDx Hematologic Malignancies Detection Product and Solutions
2.1.4 ArcherDx Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ArcherDx Recent Developments and Future Plans
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Product and Solutions
2.2.4 Bio-Rad Laboratories Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.3 sysmex
2.3.1 sysmex Details
2.3.2 sysmex Major Business
2.3.3 sysmex Hematologic Malignancies Detection Product and Solutions
2.3.4 sysmex Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 sysmex Recent Developments and Future Plans
2.4 Invitae
2.4.1 Invitae Details
2.4.2 Invitae Major Business
2.4.3 Invitae Hematologic Malignancies Detection Product and Solutions
2.4.4 Invitae Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Invitae Recent Developments and Future Plans
2.5 NeoGenomics Laboratories
2.5.1 NeoGenomics Laboratories Details
2.5.2 NeoGenomics Laboratories Major Business
2.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Product and Solutions
2.5.4 NeoGenomics Laboratories Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.6 Abbott Laboratories
2.6.1 Abbott Laboratories Details
2.6.2 Abbott Laboratories Major Business
2.6.3 Abbott Laboratories Hematologic Malignancies Detection Product and Solutions
2.6.4 Abbott Laboratories Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abbott Laboratories Recent Developments and Future Plans
2.7 Cancer Genetics
2.7.1 Cancer Genetics Details
2.7.2 Cancer Genetics Major Business
2.7.3 Cancer Genetics Hematologic Malignancies Detection Product and Solutions
2.7.4 Cancer Genetics Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cancer Genetics Recent Developments and Future Plans
2.8 Adaptive Biotechnologies Corporation
2.8.1 Adaptive Biotechnologies Corporation Details
2.8.2 Adaptive Biotechnologies Corporation Major Business
2.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product and Solutions
2.8.4 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Adaptive Biotechnologies Corporation Recent Developments and Future Plans
2.9 Asuragen
2.9.1 Asuragen Details
2.9.2 Asuragen Major Business
2.9.3 Asuragen Hematologic Malignancies Detection Product and Solutions
2.9.4 Asuragen Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Asuragen Recent Developments and Future Plans
2.10 Invivoscribe
2.10.1 Invivoscribe Details
2.10.2 Invivoscribe Major Business
2.10.3 Invivoscribe Hematologic Malignancies Detection Product and Solutions
2.10.4 Invivoscribe Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Invivoscribe Recent Developments and Future Plans
2.11 Nanjing Shihejiyin Technology
2.11.1 Nanjing Shihejiyin Technology Details
2.11.2 Nanjing Shihejiyin Technology Major Business
2.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product and Solutions
2.11.4 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Nanjing Shihejiyin Technology Recent Developments and Future Plans
2.12 Annaroad Gene Technology
2.12.1 Annaroad Gene Technology Details
2.12.2 Annaroad Gene Technology Major Business
2.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Product and Solutions
2.12.4 Annaroad Gene Technology Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Annaroad Gene Technology Recent Developments and Future Plans
2.13 BGI Genomics
2.13.1 BGI Genomics Details
2.13.2 BGI Genomics Major Business
2.13.3 BGI Genomics Hematologic Malignancies Detection Product and Solutions
2.13.4 BGI Genomics Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 BGI Genomics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hematologic Malignancies Detection Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Hematologic Malignancies Detection by Company Revenue
3.2.2 Top 3 Hematologic Malignancies Detection Players Market Share in 2022
3.2.3 Top 6 Hematologic Malignancies Detection Players Market Share in 2022
3.3 Hematologic Malignancies Detection Market: Overall Company Footprint Analysis
3.3.1 Hematologic Malignancies Detection Market: Region Footprint
3.3.2 Hematologic Malignancies Detection Market: Company Product Type Footprint
3.3.3 Hematologic Malignancies Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Hematologic Malignancies Detection Consumption Value and Market Share by Type (2018-2023)
4.2 Global Hematologic Malignancies Detection Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Hematologic Malignancies Detection Consumption Value Market Share by Application (2018-2023)
5.2 Global Hematologic Malignancies Detection Market Forecast by Application (2024-2029)
6 North America
6.1 North America Hematologic Malignancies Detection Consumption Value by Type (2018-2029)
6.2 North America Hematologic Malignancies Detection Consumption Value by Application (2018-2029)
6.3 North America Hematologic Malignancies Detection Market Size by Country
6.3.1 North America Hematologic Malignancies Detection Consumption Value by Country (2018-2029)
6.3.2 United States Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
6.3.3 Canada Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
6.3.4 Mexico Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Hematologic Malignancies Detection Consumption Value by Type (2018-2029)
7.2 Europe Hematologic Malignancies Detection Consumption Value by Application (2018-2029)
7.3 Europe Hematologic Malignancies Detection Market Size by Country
7.3.1 Europe Hematologic Malignancies Detection Consumption Value by Country (2018-2029)
7.3.2 Germany Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
7.3.3 France Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
7.3.5 Russia Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
7.3.6 Italy Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Hematologic Malignancies Detection Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Hematologic Malignancies Detection Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Hematologic Malignancies Detection Market Size by Region
8.3.1 Asia-Pacific Hematologic Malignancies Detection Consumption Value by Region (2018-2029)
8.3.2 China Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
8.3.3 Japan Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
8.3.4 South Korea Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
8.3.5 India Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
8.3.7 Australia Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
9 South America
9.1 South America Hematologic Malignancies Detection Consumption Value by Type (2018-2029)
9.2 South America Hematologic Malignancies Detection Consumption Value by Application (2018-2029)
9.3 South America Hematologic Malignancies Detection Market Size by Country
9.3.1 South America Hematologic Malignancies Detection Consumption Value by Country (2018-2029)
9.3.2 Brazil Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
9.3.3 Argentina Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Hematologic Malignancies Detection Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Hematologic Malignancies Detection Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Hematologic Malignancies Detection Market Size by Country
10.3.1 Middle East & Africa Hematologic Malignancies Detection Consumption Value by Country (2018-2029)
10.3.2 Turkey Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
10.3.4 UAE Hematologic Malignancies Detection Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Hematologic Malignancies Detection Market Drivers
11.2 Hematologic Malignancies Detection Market Restraints
11.3 Hematologic Malignancies Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Hematologic Malignancies Detection Industry Chain
12.2 Hematologic Malignancies Detection Upstream Analysis
12.3 Hematologic Malignancies Detection Midstream Analysis
12.4 Hematologic Malignancies Detection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock